Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethnicity and antidepressant response

J J Sramek1, E H Pi

  • 1California Clinical Trials, Beverly Hills 90211, USA.

The Mount Sinai Journal of Medicine, New York
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Journal of human hypertension·2002
Same author

Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults.

Journal of clinical pharmacology·2002
Same author

Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease.

Journal of clinical pharmacology·2001
Same author

Ethnicity and psychopharmacology.

Ethnicity & disease·2001
Same author

The status of ongoing trials for mild cognitive impairment.

Expert opinion on investigational drugs·2001
Same author

Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development.

Progress in neuro-psychopharmacology & biological psychiatry·2001
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Genetic variations influence antidepressant drug metabolism, leading to significant interindividual and racial differences in drug response. Understanding these factors is crucial for effective psychopharmacology.

Area of Science:

  • Pharmacology
  • Genetics
  • Cross-cultural studies

Background:

  • Interindividual differences in antidepressant plasma concentrations are significant.
  • Genetic factors, particularly slow hydroxylator phenotypes, explain extreme variations.
  • Racial differences in slow metabolizer frequencies are increasingly recognized.

Purpose of the Study:

  • To review the field of cross-cultural psychopharmacology.
  • To explore the impact of societal, cultural, environmental, genetic, and biophysiological factors on antidepressant prescribing, metabolism, and response.

Main Methods:

  • Literature review of cross-cultural psychopharmacology studies.
  • Analysis of genetic, environmental, and societal influences on drug response.

Related Experiment Videos

Main Results:

  • Anecdotal reports and prescribing surveys suggest racial differences in antidepressant dosage requirements.
  • Genetics and metabolism significantly impact drug efficacy and safety.

Conclusions:

  • Cross-cultural psychopharmacology is essential for personalized antidepressant therapy.
  • Further research is needed to elucidate the complex interplay of factors influencing antidepressant treatment outcomes across diverse populations.